Literature DB >> 16406480

Antidepressant drugs during pregnancy and infant congenital heart defect.

Bengt Källén, Petra Otterblad Olausson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406480     DOI: 10.1016/j.reprotox.2005.11.006

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


× No keyword cloud information.
  29 in total

1.  Prescribing antidepressants to pregnant women: what is a family physician to do?

Authors:  Adrienne Einarson; Gideon Koren
Journal:  Can Fam Physician       Date:  2007-09       Impact factor: 3.275

Review 2.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

3.  Prevalence and patterns of antidepressant drug use during pregnancy.

Authors:  Tessa Ververs; Hans Kaasenbrood; Gerard Visser; Fred Schobben; Lolkje de Jong-van den Berg; Toine Egberts
Journal:  Eur J Clin Pharmacol       Date:  2006-08-08       Impact factor: 2.953

4.  The inhibition characteristics of human placental glutathione S-transferase-π by tricyclic antidepressants: amitriptyline and clomipramine.

Authors:  Ozlem Dalmizrak; Gulnihal Kulaksiz-Erkmen; Nazmi Ozer
Journal:  Mol Cell Biochem       Date:  2011-05-13       Impact factor: 3.396

Review 5.  Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.

Authors:  Matthew E Glover; Sarah M Clinton
Journal:  Int J Dev Neurosci       Date:  2016-05-07       Impact factor: 2.457

6.  Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.

Authors:  Holly J Engelstad; Robert D Roghair; Chadi A Calarge; Tarah T Colaizy; Scott Stuart; Sarah E Haskell
Journal:  Neonatology       Date:  2013-12-18       Impact factor: 4.035

7.  Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.

Authors:  Marian K Bakker; Pieternel Kölling; Paul B van den Berg; Hermien E K de Walle; Lolkje T W de Jong van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-10-22       Impact factor: 4.335

Review 8.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

Review 9.  Developmental origins of health and disease: environmental exposures.

Authors:  James M Swanson; Sonja Entringer; Claudia Buss; Pathik D Wadhwa
Journal:  Semin Reprod Med       Date:  2009-08-26       Impact factor: 1.303

Review 10.  The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

Authors:  Kimberly A Yonkers; Katherine L Wisner; Donna E Stewart; Tim F Oberlander; Diana L Dell; Nada Stotland; Susan Ramin; Linda Chaudron; Charles Lockwood
Journal:  Gen Hosp Psychiatry       Date:  2009 Sep-Oct       Impact factor: 3.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.